Literature DB >> 8142218

Prognostic indicators in children with IgA nephropathy--report of the Southwest Pediatric Nephrology Study Group.

R J Hogg1, F G Silva, R J Wyatt, J S Reisch, J C Argyle, D A Savino.   

Abstract

Investigators in 13 pediatric nephrology centers reviewed clinical and pathological features in 218 children and adolescents with IgA nephropathy (IgAN), with particular emphasis on 80 patients who had follow-up periods of at least 4 years. Potential prognostic markers in the 80 children were compared between 12 (15%) who developed end-stage renal disease (ESRD) versus 68 who did not. The relationship between clinical and pathological features and the subsequent development of ESRD was examined using stepwise linear discriminant analysis in addition to standard univariate analysis. Seven variables were found to be predictive of ESRD: the presence of glomerular sclerotic changes, especially when this was associated with proliferation or sclerosis in 20% or more of the glomeruli; black race; hypertension at biopsy; proteinuria at biopsy; age at presentation; crescents; male sex. Using the resulting discriminant function, development of ESRD could be correctly predicted in 95% of the subjects. We conclude that ESRD is more common in American children with IgAN than was realized previously. Risk factors previously documented in adult studies have been confirmed, especially the presence of glomerular sclerosis, proteinuria, and hypertension.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8142218     DOI: 10.1007/bf00868251

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  32 in total

1.  Long-term follow up of renal function in IgA nephropathy.

Authors:  U B Berg
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

2.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

3.  IgA nephropathy in patients followed-up for at least ten years.

Authors:  A R Clarkson; A J Woodroffe; I Aarons
Journal:  Semin Nephrol       Date:  1987-12       Impact factor: 5.299

4.  Prognostic indicators in idiopathic IgA mesangial nephropathy.

Authors:  G D'Amico; L Minetti; C Ponticelli; G Fellin; F Ferrario; G Barbiano di Belgioioso; E Imbasciati; A Ragni; S Bertoli; G Fogazzi
Journal:  Q J Med       Date:  1986-04

5.  Idiopathic recurrent macroscopic hematuria and mesangial IgA-IgG deposits in children (Berger's disease).

Authors:  M Levy; H Beaufils; M C Gubler; R Habib
Journal:  Clin Nephrol       Date:  1972 Mar-Apr       Impact factor: 0.975

6.  Racial difference in the prevalence of IgA-associated nephropathies.

Authors:  J H Galla; E C Kohaut; R Alexander; J Mestecky
Journal:  Lancet       Date:  1984-09-01       Impact factor: 79.321

7.  IgA nephropathy in children.

Authors:  N Yoshikawa; T Matsuo
Journal:  Compr Ther       Date:  1984-05

8.  Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses.

Authors:  E Alamartine; J C Sabatier; C Guerin; J M Berliet; F Berthoux
Journal:  Am J Kidney Dis       Date:  1991-07       Impact factor: 8.860

9.  The natural history of IgA nephritis in Singapore.

Authors:  K T Woo; R P Edmondson; A Y Wu; G S Chiang; H S Pwee; C H Lim
Journal:  Clin Nephrol       Date:  1986-01       Impact factor: 0.975

10.  Iga nephropathy: presentation, clinical course, and prognosis in children and adults.

Authors:  R J Wyatt; B A Julian; D B Bhathena; B L Mitchell; N H Holland; H H Malluche
Journal:  Am J Kidney Dis       Date:  1984-09       Impact factor: 8.860

View more
  25 in total

1.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

Review 2.  Pathology of IgA nephropathy.

Authors:  Ian S D Roberts
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

3.  The difficulty in considering modifiable pathology risk factors in children with IgA nephropathy: crescents and timing of renal biopsy.

Authors:  Rosanna Coppo; Jean-Claude Davin
Journal:  Pediatr Nephrol       Date:  2014-10-16       Impact factor: 3.714

4.  Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.

Authors:  Xia-Hong Shen; Shao-Shan Liang; Hui-Mei Chen; Wei-Bo Le; Song Jiang; Cai-Hong Zeng; Min-Lin Zhou; Hai-Tao Zhang; Zhi-Hong Liu
Journal:  J Nephrol       Date:  2015-01-14       Impact factor: 3.902

5.  Efficacy of tonsillectomy pulse therapy versus multiple-drug therapy for IgA nephropathy.

Authors:  Yukihiko Kawasaki; Kei Takano; Kazuhide Suyama; Masato Isome; Hideki Suzuki; Hiroko Sakuma; Tomoo Fujiki; Hitoshi Suzuki; Mitsuaki Hosoya
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

6.  Treatment of IgA nephropathy in children.

Authors:  U S Alon
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

7.  Validation study of oxford classification of IgA nephropathy: the significance of extracapillary proliferation.

Authors:  Ritsuko Katafuchi; Toshiharu Ninomiya; Masaharu Nagata; Koji Mitsuiki; Hideki Hirakata
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

8.  Risk factors for persistent proteinuria after a 2-year combination therapy for severe childhood IgA nephropathy.

Authors:  Koichi Kamei; Koichi Nakanishi; Shuichi Ito; Kenji Ishikura; Hiroshi Hataya; Masataka Honda; Kandai Nozu; Kazumoto Iijima; Yuko Shima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2014-12-10       Impact factor: 3.714

9.  Treatment of severe Henoch-Schönlein and immunoglobulin A nephritis. A single center experience.

Authors:  Stella Edström Halling; Magnus P Söderberg; Ulla B Berg
Journal:  Pediatr Nephrol       Date:  2008-10-18       Impact factor: 3.714

Review 10.  Idiopathic immunoglobulin A nephropathy in children and adolescents.

Authors:  Ronald J Hogg
Journal:  Pediatr Nephrol       Date:  2009-02-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.